Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19 (PED-COVID)
Seroprevalence and Antibody Profiling Against SARS-CoV2 in Children and Their Parents
Sponsor: Assistance Publique - Hôpitaux de Paris
A NA clinical study on COVID-19 Infection, this trial is completed. The trial is conducted by Assistance Publique - Hôpitaux de Paris and has accumulated 14 data snapshots since 2020. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
14 versions recorded-
Feb 2026 — Present [monthly]
Completed NA
-
Sep 2025 — Feb 2026 [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Dec 2023 — Jul 2024 [monthly]
Completed NA
▶ Show 9 earlier versions
-
Mar 2023 — Dec 2023 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Sep 2022 — Mar 2023 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Oct 2021 — Sep 2022 [monthly]
Recruiting NA
-
Apr 2021 — Oct 2021 [monthly]
Recruiting NA
-
Feb 2021 — Apr 2021 [monthly]
Recruiting NA
-
Jan 2021 — Feb 2021 [monthly]
Recruiting NA
-
Sep 2020 — Jan 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jun 2020 — Sep 2020 [monthly]
Not Yet Recruiting NA
-
May 2020 — Jun 2020 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Assistance Publique - Hôpitaux de Paris
- Commissariat A L'energie Atomique
- Institut National de la Santé Et de la Recherche Médicale, France
- Institut Pasteur
- URC-CIC Paris Descartes Necker Cochin
For direct contact, visit the study record on ClinicalTrials.gov .